Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Aerie Looks To Grow Its Two Glaucoma Products In Tandem

Mar 13 2019

• By Joseph Haas

Glaucoma eye, pressure, optic, nerve, blindness, glaucoma, - Vector

Related Content

Aerie's M&A Potential Rises As Roclatan Passes Second Phase III Glaucoma Test

May 26 2017

Aerie's Rhopressa Approved Early For Glaucoma, 2018 Launch Planned

Dec 20 2017

Related Companies

Aerie Pharmaceuticals, Inc.

Pfizer Inc.

Allergan plc

Novartis AG

Additional Topics

Approvals Business Strategies Commercial Launches Ophthalmic BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.